Document Detail

Informing policy for the Australian context - Costs, outcomes and cost savings of prenatal carrier screening for cystic fibrosis.
MedLine Citation:
PMID:  20218998     Owner:  NLM     Status:  MEDLINE    
AIMS: To examine the costs, outcomes and cost savings of three models of prenatal cystic fibrosis (CF) carrier screening compared to no screening from a public health sector perspective. METHODS: A decision tree was generated to estimate costs and outcomes for each screening model for a hypothetical cohort of 38 000 pregnancies. Sensitivity analysis assessed the impact of model parameter variation. RESULTS: Under baseline assumptions, the initial annual cost to provide a prenatal CF carrier-screening programme is Au$5.32 million, Au$3.35 million and $2.93 million for one-step, two-step simultaneous and two-step sequential screening respectively. Annual costs are significantly lower for an established programme. No screening model provides a net saving over a lifetime horizon; however, the results were sensitive to variation in lifetime cost of care, screening test costs and number of pregnancies per carrier couple. CONCLUSIONS: Under some scenarios, prenatal CF carrier screening is cost saving to the health system; however, this is not conclusive and depends on several factors. Cost remains a potential barrier due to the substantial level of funding required in the short term. Feasibility and psychosocial, ethical and legal implications of screening need to be considered. Additionally, consultation is required with the Australian community on the acceptability and/or desire for prenatal CF carrier screening.
Susannah Maxwell; Kate Brameld; Leanne Youngs; Elizabeth Geelhoed; Peter O'Leary
Related Documents :
19115998 - What needs to change to increase chlamydia screening in general practice in australia? ...
19861738 - Ethical problems with neonatal screening.
9193238 - State-to-state variations in newborn screening policies.
16242958 - Using cost and health impacts to prioritize the targeted testing of tuberculosis in the...
1962538 - Group counseling with adolescent special education students: challenges and useful proc...
24220838 - Monitoring in the tualatin river basin to assess the effectiveness of the oregon forest...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Australian & New Zealand journal of obstetrics & gynaecology     Volume:  50     ISSN:  1479-828X     ISO Abbreviation:  Aust N Z J Obstet Gynaecol     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-03-11     Completed Date:  2010-07-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0001027     Medline TA:  Aust N Z J Obstet Gynaecol     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  51-9     Citation Subset:  IM    
Department of Health, Perth, WA, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cost-Benefit Analysis
Cystic Fibrosis / economics*,  genetics
Decision Trees
Health Care Costs*
Health Policy / economics*
Heterozygote Detection*
Prenatal Diagnosis / economics*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The trouble with clinical indicators: Intact lower genital tract following childbirth in NSW Hospita...
Next Document:  Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: ...